
Please try another search
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Gerald Schwank | - | 2023 | Member of Scientific Advisory Board |
Agnieszka Czechowicz | - | 2022 | Member of Scientific Advisory Board |
Shengdar Q. Tsai | - | 2022 | Member of Scientific Advisory Board |
Muthiah Manoharan | 72 | 2022 | Member of Scientific Advisory Board |
Jay Shendure | - | 2022 | Member of Scientific Advisory Board |
Jeffrey D. Marrazzo | 46 | 2023 | Executive Chair |
Samuel H. Sternberg | - | 2022 | Member of Scientific Advisory Board |
Michael A. Kelly | 68 | 2021 | Independent Director |
Anastasia Khvorova | 56 | 2022 | Member of Scientific Advisory Board |
Robert Taylor Nelsen | 63 | 2020 | Independent Director |
Wendy K. Chung | 56 | 2021 | Independent Director |
Kaye I. Foster-Cheek | 65 | 2021 | Independent Director |
Thomas J. Cahill | 38 | 2021 | Independent Director |
David P. Schenkein | 68 | 2019 | Independent Director |
Ben Kleinstiver | - | 2022 | Member of Scientific Advisory Board |
Yvonne Y. Chen | - | 2022 | Member of Scientific Advisory Board |
Guangping Gao | - | 2022 | Member of Scientific Advisory Board |
Eric N. Olson | - | - | Member of Scientific Advisory Board |
James Haber | - | 2022 | Member of Scientific Advisory Board |
Allan Reine | 50 | 2024 | CEO & Director |
David R. Liu | - | 2022 | Co-Founder & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review